By Karen Roman Biopharmaceutical company Medera Inc. said the first patient has been dosed in Phase 2 of its MUSIC-HFrEF clinical trial using gene therapy for heart failure with reduced ejection fraction. The advancement comes after a positive recommendation and...

By Brandon Hornback Whether all AI projects will be lucrative or not, they are without a doubt creating a tremendous surge in power use. Smart investors now have a way to bet that demand is here to stay. ONE Nuclear...

SPAC Deal to Create a Scalable Play on the AI-Driven Energy Opportunity Key Takeaways HVII’s merger with ONE Nuclear Energy LLC will create a differentiated public vehicle positioned at the intersection of AI-era energy demand, nuclear innovation, and U.S. infrastructure...

By Karen Roman Oncology-focused biotech company SkylineDx said results from its MERLIN_001 trial, the largest evaluation of a genomic test in cutaneous melanoma, were published in the October 2025 issue of JAMA Surgery. The study shows the test classified T1-T3...

Download the Complete Report Here By Brandon Hornback The Trump Administration’s latest foray into public equities is quantum computing. Investors keen to follow the President’s lead now have a fresh choice on the menu with Horizon Quantum Computing Pte. Ltd,...

Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

CorpGov, IPO Edge and PE Edge will host the fifth annual Palm Beach CorpGov Forum on Wednesday, Nov. 5 and Thursday, Nov, 6, 2025, at the Palm Beach Lake Pavilion, located waterfront with sweeping views of Palm Beach Island. The Forum will...

By Exec Edge Editorial Staff In an industry increasingly driven by speed and cost-cutting, Michael Shanly stands out for his belief that housebuilding should focus on lasting value rather than quick returns. The founder of Shanly Homes — which has...

By Daniella Parra Ashvattha Therapeutics has appointed Robert J. Dempsey as Interim CEO, tapping an ophthalmology veteran with a track record of transformative deals and launches, they said. Recently, Ashvattha announced positive Phase 2 results for migaldendranib, a novel subcutaneous nanomedicine showing...

Download the Complete Report Here By Brandon Hornback Whether a first-time gun owner or avid enthusiast, GrabAGun Digital Holdings Inc. (NYSE: PEW) empowers customers to confidently shop for firearms from the convenience of their home. That also creates a rifle-shot opportunity...